P
osttranslational protein modifications represent an important control mechanism regulating protein function. Besides small chemical groups like acetyl, methyl, and phosphate, proteins can also be covalently modified by a family of small proteins. 1, 2 Members of this family include ubiquitin and a dozen ubiquitin-like proteins, such as SUMO (small ubiquitin-related modifier), NEDD8 (neural precursor cell expressed, developmentally downregulated 8), ISG15 (interferon-stimulated gene 15), Ufm1 (ubiquitin-fold modifier 1), FAT10 (human leukocyte antigen-F-associated transcript 10), and Urm1 (ubiquitinrelated modifier 1).
1,2 Conjugation of these ubiquitin-like proteins to target proteins is mediated by a process analogous to ubiquitination and requires specific E1 (activating), E2 (conjugating), and E3 (ligating) enzymes. Unlike ubiquitination, the modification of proteins with ubiquitin-like proteins generally serves as nonproteolysis signals and regulates various cellular processes through altering the substrate's structure, stability, localization or protein-protein interaction. The fundamental importance of these modifications in both normal cell function and disease is gaining increasing recognition. 3, 4 Recent studies have begun to unveil crucial roles for SUMO, 5, 6 NEDD8, 7, 8 and ISG15 9 in regulating cardiac development and function under physiological conditions and on pathological insults. However, the biological function of the other ubiquitinlike proteins in the heart remains largely unknown. Ufm1 is a novel 9.1-kDa ubiquitin-like protein that is highly conserved in multicellular organisms. 10 Unlike ubiquitin and other ubiquitin-like proteins, such as SUMO and NEDD8, Ufm1 possesses a single active glycine at its C terminus, which is necessary for its attachment to target proteins. Conjugation of Ufm1 to protein targets (ufmylation) requires the homodimeric Uba5 as an E1 Ufm1-activating enzyme, Ufc1 as an E2 Ufm1 conjugating enzyme, and Ufl1 (Ufm1-specific E3 ligase 1; also known as RCAD) as an E3 Ufm1 ligase. 11 Ufl1 recruits Ufm1-conjugated Ufc1 to target proteins and transfers Ufm1 to the substrate by generation of an isopeptide bond between the C-terminal glycine of Ufm1 and the lysine residue of the substrate. [10] [11] [12] The Ufsp (Ufm1-specific protease) 1 and 2 can cleave the conjugated Ufm1 from the modified targets. 13 To date, only a few proteins have been identified as Ufm1 targets, 11, 14, 15 with Ufbp1 (Ufm1-binding protein 1, also known as DDRGK1 and C20orf116) being one of the most studied. Ufbp1 is an endoplasmic reticulum (ER)-localized protein and is ubiquitously expressed in different tissues, including the heart. 16 Ufl1 interacts with Ufbp1 and mediates the ufmylation of Ufbp1, which seems to prevent the ubiquitination and degradation of Ufbp1. 11, 17 Recent studies have begun to uncover the biological functions of the Ufm1 system. Ufmylation has been reported to regulate multiple cellular processes, including the ER stress response, 16, [18] [19] [20] fatty acid metabolism, 21 GPCR (G-protein-coupled receptor) maturation, 22 cell differentiation, [15] [16] [17] and cell cycle control. 17, 23 Polymorphisms and dysregulation of the Ufm1 system have been linked to several human diseases. Polymorphisms of Ufm1 have been found to associate with von Willebrand disease and atrophic gastritis. 24, 25 Mutations of Ufsp2 were identified in a family with Beukes familiar hip dysplasia. 26, 27 The expression of Ufl1 is elevated in human lung adenocarcinoma tissues and regulates estrogen receptor signaling in breast cancer through Ufm1 modification of ASC1 (activating signal cointegrator 1). 14, 28 Loss-of-function mutations of Uba5 have been linked to early-onset encephalopathy, 29, 30 which highlight a pivotal role of ufmylation in central nervous system development and function. Furthermore, loss of Uba5, Ufl1, or Ufbp1 in mice has consistently demonstrated an important role of ufmylation in embryonic development and hematopoiesis. 19, 20, 31 However, whether and how protein ufmylation regulates cardiac development and function has not yet been investigated.
Here, we report that Ufl1 expression is downregulated in human failing hearts and ischemic hearts of mouse models but upregulated in pressure overloaded murine hearts. To understand the role of ufmylation in the heart, we created cardiomyocyte-restricted Ufl1 CKO (Ufl1 knockout) mice. Ufl1 CKO mice developed cardiomyopathy during aging and showed a remarkably increased propensity to develop heart failure in response to hemodynamic stress. RNA sequencing analysis and biochemical assays revealed the implication of prevalent ER stress in Ufl1-deficient hearts. Loss-of-function experiments in cultured cardiomyocytes indicate that Ufl1 is required for initiation of adaptive ER stress sig-
WHAT IS NEW?
• The expression of Ufl1 (Ufm1 [ubiquitin-fold modifier 1]-specific E3 ligase 1) is upregulated in murine hypertrophied hearts and downregulated in human failing hearts.
• Ufl1 deficiency induces age-dependent cardiomyopathy and exacerbates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction. • Ufl1 deficiency impairs myocardial endoplasmic reticulum homeostasis and inhibits PERK (PKR-like ER-resident kinase) signaling.
WHAT ARE THE CLINICAL IMPLICATIONS?
• Inadequate protein ufmylation may contribute to the development of cardiomyopathy.
• Upregulation of myocardial Ufl1 levels could be a future therapeutic option in heart failure.
• Targeting ufmylation could be a new strategy for treatment of diseases associating with endoplasmic reticulum stress.
naling. Lastly, pharmacological inhibition of ER stress attenuated pressure overload-induced heart failure in Ufl1-deficient hearts. Thus, our data demonstrate an essential role of Ufm1 modification in the heart under physiological and pathological conditions and reveal a critical role of Ufl1 in mediating adaptive ER stress response in cardiomyocytes.
MATERIALS AND METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. This would be accomplished on reasonable and direct request with the corresponding author by email.
Animal Models
Generation of a transgenic mouse line bearing an Ufl1 conditional-knockout allele (Ufl1 flox ) was described previously. 19 The mutant mice were bred to αMHC Cre (α-myosin heavy chain promoter-driven Cre transgenic) mice 32 (The Jackson Laboratory; No. 011038) to generate cardiomyocyte-restricted Ufl1 CKO mice. These mice were maintained in the C57BL/6J inbred background for our studies. All animal experiments were approved by the Augusta University Institutional Animal Care and Use Committee.
Some of the animals were treated daily with vehicle (0.15 mol/L NaHCO 3 , pH7.4) or vehicle-containing tauroursodeoxycholic acid (TUDCA; 250 mg/kg; EMD Chemicals) through gavage feeding for 2 weeks, starting immediately after transverse aortic constriction (TAC) surgery.
Human Samples
Human heart tissue biopsies from patients with end-stage heart failure because of dilated cardiomyopathy and nonfailing controls were retrieved from the archive of the Department of Cardiac Pathology and Laboratory of Electrophysiology at the Texas Heart Institute. Control samples were obtained from donors without a history of cardiovascular disorders, whose hearts could not be used for transplantation because of medical or technical reasons. The protocol for the use of human heart samples was reviewed and exempted by the Institutional Review Board at St. Luke Episcopal Hospital.
Surgical Procedures
To generate a mouse model of myocardial ischemia/reperfusion, mice were anesthetized using 1% isoflurane, intubated through the mouth, and ventilated at normal rate. The left anterior descending coronary artery was ligated against a PE10 tubing with an 8 to 10 nylon suture. After 30 minutes of ligation, the ligature was released to allow reperfusion for another 24 hours. Sham-operated animals were subjected to the same procedure without ligation of the suture.
To create a mouse model of pressure overload, mice were subjected to TAC. Briefly, mice were anesthetized and ventilated as described above. The transverse aorta was exposed and constricted by banding a 27-gauge needle to the aorta with a suture. The needle served as a uniform model for the constriction and was removed immediately after the ligation of the suture.
Echocardiography
Transthoracic echocardiography was performed with a linear 30-MHz transducer using a VEVO 2100 echocardiography system (VisualSonics). The left ventricular (LV) morphometric and functional parameters were analyzed offline using VEVO 2100 software.
RNA-Seq and Kyoto Encyclopedia of Genes and Genomes Analysis
RNAs for 4 control and 3 Ufl1 CKO mice at 2 months of age were extracted using RNeasy Fibrous Tissue Mini Kit (Qiagen). RNASeq libraries were prepared using the Illumina TruSeq RNA Kit v2 with 500 ng of total RNA. Library sequencing was run on an Illumina HiSeq 2500 at the Genome Technology Access Center at Washington University. Approximately, 20 million reads per sample were generated. Sequencing results were demultiplexed and converted to FASTQ format using Illumina Bcl2FastQ software and aligned to the mouse genome (build mm10/GRCm38) with spliced transcripts alignment to a reference. 33 Counts for each transcript were generated using HTSeq package, 34 normalized to the length of the individual transcript and to the total mapped read counts in each sample, and expressed in counts per millions. For each gene, we compared the expression levels between control (CTL) and Ufl1 CKO RNAs. Gene expression differences were evaluated using Fisher exact test after normalizing by the total number of mapped reads in each lane. The resulting P values were corrected via the Benjamini and Hochberg method. Differentially expressed genes were defined as those with log 2 changes of at least 1.3-fold between a pair of samples at false discovery rate of 0.05 for genes with a count >10. The functional annotation of these genes was analyzed using DAVID. 35 Differentially expressed genes were used as input gene list, and all mouse genes that were expressed in the heart were used as the background. We looked for enrichment for genetic association with Kyoto Encyclopedia of Genes and Genomes pathways. Data set was analyzed using R software, version 3, and ad hoc packages.
Statistical Analysis
Results are shown as mean±SD. Paired data were evaluated using a 2-tailed Student t test. For multiple comparisons, 1-way ANOVA or when appropriate, 2-way ANOVA, followed by post hoc test, was performed. A P value <0.05 was considered statistically significant.
Detailed methods on real-time polymerase chain reaction, histology and immunohistochemistry analysis, cell culture, and Western blot analysis are described in the Data Supplement.
RESULTS

Protein Ufmylation in Cardiac Development and Disease
The role of protein ufmylation in cardiac development and disease has not yet been determined. We first confirmed that Ufm1 is expressed in the adult mouse hearts by quantitative real-time polymerase chain reaction analysis (data not shown), and levels were found to be comparable with SUMO 1/2/3-a relatively wellstudied ubiquitin-like protein in the heart. During mouse development, the abundance of Ufm1-conjugated (ufmylated) proteins were gradually increased; however, the expression of Ufm1 E3 ligase Ufl1 was reduced in aging hearts ( Figure 1A ), indicating that a low level of Ufl1 protein is sufficient to mediate protein ufmylation in adult cardiomyocytes. We next created mouse models of cardiac hypertrophy by TAC. Western blot analysis showed that 2 weeks of pressure overload resulted in a concomitant increase of ufmylated proteins (≈1.4-fold) and Ufl1 proteins (≈1.6-fold) in mouse hearts ( Figure 1B) , suggesting that hemodynamic stress may activate protein ufmylation in the heart in a Ufl1-dependent manner. In mouse hearts subjected to ischemia/reperfusion surgery, Ufl1 expression was significantly reduced in the ischemic and border zones of the infarct area ( Figure 1C ). The reduction of Ufl1 expression in ischemic myocardium was further confirmed by immunostaining and was evident in necrotic cardiomyocytes as revealed by an Evans blue dye infiltration assay ( Figure 1D ), implicating the potential role of Ufl1 in the regulation of cardiomyocyte survival. Moreover, Western blot analysis of human LV samples from 4 patients with dilated cardiomyopathy and 4 control donors revealed the decreased expression of Ufl1 (Figure 1E) . Thus, protein ufmylation may have an important role in cardiac development and disease.
Creation of Cardiomyocyte-Restricted Ufl1 CKO Mice
We have previously generated mice carrying Ufl1 flox alleles, wherein exon 7 was flanked by loxP sites. 19 We then crossed these Ufl1 flox mice with αMHC Cre mice 32 to achieve cardiomyocyte-restricted knockout of Ufl1 ( ) mice, we determined that the transcript and protein levels of Ufl1 were dose-depend- Figure 2D ). These data collectively indicate that Ufl1, in part, regulates ufmylation in cardiomyocytes.
Ufl1 Is Required for Physiological Cardiac Growth and Function
To determine whether Ufl1 regulates physiological growth of the heart, we characterized the cardiac phenotypes of Ufl1 CKO mice over time. Ufl1 CKO mice were born at the expected Mendelian ratio, and Ufl1 CKO hearts were morphologically indistinguishable from CTL hearts at birth. At 2 months of age, Ufl1
CKO hearts began to show signs of pathological cardiac remodeling, as evidenced by slightly but significantly reduced heart weight-to-tibial length ratios and the upregulation of Bnp, Myh7, and α-skeletal actin, fetal genes that are often associated with pathological cardiac remodeling 36 ( Figure 3A and 3B). From 2 to 6 months after birth, temporal echocardiography analysis demonstrated a progressive deterioration of cardiac function in Ufl1 CKO mice (Figure 3C and 3D; Figure 3A and 3B). Histopathology confirmed decreased heart size, LV wall thinning, and LV chamber dilatation ( Figure 3E and 3F) . Masson trichrome staining ( Figure 3G and 3H) revealed that there was accompanying interstitial fibrosis in the free wall of Ufl1 CKO LVs. These data indicate that cardiomyocytespecific knockout of Ufl1 induced severe cardiomyopathy, suggesting a critical role of ufmylation in regulating physiological cardiac growth and maintaining cardiac function.
Ufl1 Protects Against Pressure OverloadInduced Heart Failure
Ufl1 expression is upregulated in hypertrophic mouse hearts ( Figure 1B) . We hypothesized that myocardial upregulation of Ufl1 is cardioprotective against pathological cardiac remodeling induced by pressure over- load. To assess this, TAC was applied to CTL and Ufl1 CKO mice at 2 months of age-a time when their cardiac function is comparable ( Figure 3D ; Table I in the Data Supplement). As expected, pressure overload provoked compensatory hypertrophy in CTL mice at 2 weeks post-TAC, as indicated by increased LV wall thickness, the absence of LV chamber dilation, and preserved LV contractility (Figure 4A and 4B; Table II in the Data Supplement), along with increased heart weight as compared with sham-operated mice ( Figure 4F ). However, despite the equivalent pressure overload as revealed by measurement of the pressure gradient across the constricted aortas ( Figure 3B ), Ufl1 CKO mice subjected to TAC bypassed the compensatory hypertrophy stage and quickly developed heart failure. This is demonstrated by absence of an increase in LV wall thickness, drastic LV chamber dilatation, and significantly impaired contractility when compared with CTL+TAC mice (ejection fraction: 46.5±17.2% versus 66.1±11.3% of CTL+TAC; fractional shortening: 21.1±8.9% versus 36.3±7.9% of CTL+TAC; Figure 4A and 4B; Table II in the Data Supplement). Histopathology further confirmed LV chamber dilatation of Ufl1 CKO hearts post-TAC ( Figure 4C ). Gravimetric analysis showed that Ufl1 CKO mice had a greater increase in heart weight-to-body weight ratio and a significant increase in lung weight-to-tibial length ratio after TAC (Figure 4E ), indicative of LV failure. Moreover, TAC-induced myocardial interstitial fibrosis and reactivation of fetal genes (Myh7) became more pronounced in the Ufl1 CKO hearts ( Figure 3D , 3E, 3G, and 3H). Thus, the rapid-onset dilated cardiomyopathy and heart failure in pressure overloaded Ufl1 CKO mice demonstrate the importance of Ufl1 in regulating adaptive cardiac remodeling in response to hemodynamic stress. 
Differential Transcriptome of Ufl1
CKO
Hearts
To identify the cellular pathways that are specifically regulated by Ufl1, we performed RNA sequencing to measure global gene expression in CTL and Ufl1 CKO hearts at 2 months of age, when their function is comparable. A total of 41 388 annotated genes from the Ensembl reference database were tested for differential expression. Stringent threshold criteria (count, >10; false discovery rate; log 2 FC, ±0.3; false discovery rate, <0.05) resulted in 967 genes differentially expressed between CTL and Ufl1 CKO hearts; 319 genes were downregulated, and 648 genes were upregulated in the Ufl1 CKO hearts when compared with controls ( Figure 5A ; Table I in the Data Supplement). A heatmap revealed a high level of homogeneity and excellent consistency of the changes within groups ( Figure 5B) .
A Kyoto Encyclopedia of Genes and Genomes functional network analysis of the 970 dysregulated genes indicated that the highest significance was in the metabolic pathway, and the second highest significance was in protein processing in ER ( Figure 5C ). Pathways related to ribosome, protein export, calcium signaling pathway, and tight junction, among others, were also prominent, emphasizing the potential roles of Ufl1 in the regulation of these processes. Interestingly, arrhythmogenic right ventricular cardiomyopathy and viral myocarditis also scored with high significance, consistent with the aforementioned critical role of Ufl1 in the maintenance 
Two-month-old control (CTL) and Ufl1
CKO mice were subjected to either sham (n=5 for CTL and 5 for KO) or TAC (n=8 for CTL and 11 for KO) operation for 2 wk. A and B, Temporal echocardiography analysis of left ventricular (LV) functions. Representative M-mode images at 2 wk post-operation (A), the pressure gradients across constricted aorta, and the temporal changes of LV morphometry and function (B) are shown. *P<0.05, **P<0.01, ***P<0.001 vs CTL+TAC at indicated times. C-E, Representative images of H&E-stained (C) and Masson trichrome-stained (D) myocardium sections. Bars in C and D are 1 mm and 100 μm, respectively. E, Ratios of heart weight (Hw)-to-tibial length (TL) and lung weight to TL. F and G, The quantification of fibrotic area (F) and Mhy7 mRNA expression (G). *P<0.05. of cardiac function. Because protein ufmylation has been closely linked to ER homeostasis, 19, 20, 37 we focused on the protein processing in ER pathways. Several ERlocalized metabolic enzymes, such as Aldob (coding for adolase B) and Cyp26b1 (coding for cytochrome P450, family 26, subfamily b), were significantly downregulated in Ufl1 CKO hearts, whereas ER-resident protein transporter Lman1l (Lectin, Mannose Binding 1 Like) and heat shock proteins (Hspa1l, Hsp90aa1, and Hspb1) were significantly upregulated. The positions of these genes in the volcano plot are depicted in Figure 5D . qPCR with gene-specific primers further confirmed the dysregulation of these genes in 2-month-old Ufl1 CKO hearts ( Figure 5E ). Of note, Aldob belongs to a family of glycolytic enzymes that associate with cardiac ATPsensitive K + channel, 38 whereas Cyp26b1 negatively regulates Ca 2+ in ER by degrading retinoic acid, 39 which mediates signaling essential for heart development 40 and adaptive cardiac remodeling. 41 Because normal ER function is essential for Ca 2+ cycling and the quality 
RNAs isolated from 2-mo control (CTL) (n=4) and Ufl1
CKO (n=3) hearts were used for RNA sequencing analysis. A, Illustration of RNA sequencing analysis. B, Gene clustering by Z score showing consistency within groups. C, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis shows significantly enriched pathways in Ufl1 CKO hearts. Gene set related to endoplasmic reticulum (ER) homeostasis is highlighted. D, Volcano plot of downregulated (green) and upregulated (red) transcripts in Ufl1 CKO hearts. ER-related, differentially expressed transcripts, as well as Ufl1 transcript, are marked by dark dots and blue triangle, respectively. Transcripts that were not differentially expressed are in gray. E, Quantitative real-time polymerase chain reaction confirmation of mRNA expression of ER-related, differentially expressed genes (n=4). *P<0.05 vs CTL. n.s. indicates nonsignificant; and u.d., not detected.
control of secretory proteins, dysregulation of ER-associated regulators of intracellular ion exchange and heat shock proteins in Ufl1 CKO hearts implicates a possible role of Ufl1 in the regulation of ER homeostasis.
Loss of Ufl1 Induces ER Stress in the Heart
Perturbation of ER-associated functions can result in the accumulation of unfolded or misfolded proteins in the ER lumen-a condition termed as ER stress. ER stress is implicated in and contributes to the pathogenesis of various forms of cardiac disease. 42, 43 Accordingly, we next determined whether the loss of Ufl1 induces ER stress in the heart. BiP (immunoglobulin-binding protein, also known as Grp78 [glucose-regulated protein, 78 kDa]) and PDI (protein disulfide isomerase) are 2 ER stress-responsive chaperone proteins that are critical for the activation of the unfolded protein response (UPR) and protein folding, respectively. 44, 45 Western blot analysis of myocardial lysates from 2-month-old CTL and Ufl1 CKO mice showed a significant increase in PDI, as well as the nonspecific chaperones Hsp40 and Hsp90, in Ufl1
CKO hearts (Figure 6A) . The upregulation of these proteins, along with the levels of BiP and Grp94 proteins, was further augmented in Ufl1
CKO hearts with established cardiomyopathy (at 6 months of age; Figure 6A and 6B). Moreover, CHOP (CCAAT/enhancer-binding protein homologous protein)-a key mediator of ER stress-induced cell death 46, 47 -was also drastically upregulated in Ufl1 CKO hearts at 6 months of age. We also observed an upregulation of PDI and BiP in Ufl1 CKO +TAC hearts compared with CTL+TAC hearts and a greater upregulation of PDI in Ufl1 CKO +TAC hearts compared with their sham counterparts ( Figure 6C and 6D) . Moreover, ultrastructural analysis of the ER using electron microscopy revealed massive proliferative and dilated ERs, both hallmarks of ER stress, in Ufl1-deficient cardiomyocytes ( Figure 6E ). In agreement with the notion that persistent ER stress results in cell death, there was a significant increase in terminal deoxynucleotidyl transferase dUTP nick end labeling+ cardiomyocytes in Ufl1 CKO hearts subjected to 2 weeks of TAC ( Figure 6F and 6G) . Our results suggest that excessive ER stress precedes the onset of cardiomyopathy and then deteriorates along with disease progression in Ufl1 CKO hearts, providing evidence in support of a potential causative role.
Ufl1 Is Necessary for PERK (PKR-like ERresident kinase) Activation and Protects Against ER Stress-Induced Cell Death in Cardiomyocytes
ER stress triggers a complex signaling network known as the UPR with the goal of maintaining ER homeostasis. The UPR is mediated by 3 ER membrane-located transducers, PERK, IRE1α (inositol-requiring enzyme 1), and ATF6 (activating transcription factor 6), and collectively functions to reduce protein synthesis, enhance refolding, increase proteolysis of misfolded proteins, and selectively upregulate the expression of protective proteins. 42, 43 To understand the role of Ufl1 in regulating UPR, we silenced Ufl1 in neonatal rat ventricular cardiomyocytes and treated the cells with the ER stress inducers thapsigargin or tunicamycin. Ufl1 silencing effectively diminished tunicamycin-induced increase in phosphorylation of PERK and eIF2α, as well as the increase in the PERK downstream target ATF4 (activating transcription factor 4) ( Figure 7A and 7B), indicating defects in activating PERK signaling. In contrast, silencing of Ufl1 did not affect the expression of BiP, calreticulin, PDI, or ERp44 (endoplasmic reticulum protein 44), which are downstream of ATF6 signaling. 42 Moreover, silencing of Ufl1 enhanced thapsigargin-and tunicamycin-induced cardiomyocyte apoptosis, and this is evidenced by the increased cleavage of caspase 12-a major mediator of ER stress-specific apoptosis, 48 as well as by the increased cleavage of the general apoptosis executor caspase 3 ( Figure 7C ). Consistently, silencing of Ufl1 reduced the viability of neonatal rat ventricular cardiomyocytes on thapsigargin and tunicamycin treatment ( Figure 7D ). Thus, our results indicate that the loss of Ufl1 inhibits PERK signaling and renders cardiomyocytes more susceptible to ER stress-induced cell death.
TUDCA Administration Ameliorates TAC-Induced Cardiac Phenotype of Ufl1 CKO Mice
TUDCA is a classic chemical chaperone that has been shown to alleviate ER stress in vitro and in vivo by enhancing ER folding capacity. 49 To determine whether excessive ER stress is the driving force that sensitizes Ufl1-deficient hearts to hemodynamic stress, we subjected 2-monthold CTL and Ufl1 CKO mice to TAC surgery and administered TUDCA (250 mg/kg per day) through daily intraperitoneal injections for 2 weeks. As shown in Figure 8A , TUDCA markedly attenuated TAC-induced enlargement of Ufl1 CKO hearts. This is confirmed by a decreased heart weight-to-tibial length ratio in Ufl1 CKO +TAC hearts after TUDCA treatment ( Figure 8B ). Moreover, there was also a significant decrease in the lung weight-to-tibial length ratio in Ufl1 CKO +TAC+TUDCA hearts when compared with Ufl1 CKO +TAC hearts ( Figure 8C ). We also performed echocardiography to determine heart function. Although TUDCA administration did not have any impact on the function of CTL+TAC hearts because of preserved heart function at this stage ( Figure 8D ; Table III in the Data Supplement), it significantly suppressed LV dilatation and improved LV contractility in Ufl1 CKO +TAC hearts. This is indicated by a reduction in LV internal chamber diameter at both systolic and dia-stolic phase, as well as an increase in LV ejection fraction in Ufl1 CKO +TAC+TUDCA hearts compared with their vehicle-treated counterparts ( Figure 8D ; Table III in the Data Supplement). TUDCA treatment also significantly reduced TAC-induced cardiomyocyte apoptosis in the Ufl1 CKO hearts ( Figure 8E ). Lastly, Western blot analysis demonstrated that TUDCA blunted the upregulation of PDI in Ufl1 CKO hearts, validating the effectiveness of TUDCA on alleviation of ER stress ( Figure 8F and 8G) . Together, our data suggest that alleviation of ER stress mitigates TAC-induced cardiac dysfunction in Ufl1 CKO hearts. B and D) of the indicated ER stress-responsive proteins in heart extracts from 2-and 6-mo-old mice (A and B; n=3) or 2-mo-old mice subjected to sham or transverse aortic constriction (TAC) for 2 wk (C and D; n=4). In (A), an anti-KDEL antibody (Santa Cruz; No. 58774) was used to simultaneously detect Grp94 and BiP (immunoglobulin-binding protein). In (C), an anti-BiP antibody (Cell Signal; No. 3183S) was used to specifically detect BiP. *A nonspecific band. E, Electron micrographs of ventricular sections from 4-mo-old mice. Abnormal ER cisternae (arrows) are shown. Three mice per group were analyzed. F and G, Representative images (F) and the quantification (G) of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)+ (red, arrows) cardiomyocytes in myocardium sections (n=3 for sham group, n=4 for TAC group). Cardiomyocytes and nuclei were counterstained by phalloidin (green) and 4',6-diamidino-2-phenylindole, respectively (bar=50 μm). * P<0.05, ** P<0.01. #P<0.05 vs KO+Sham.
DISCUSSION
In summary, our findings demonstrate for the first time that Ufl1-an E3 ligase for a novel ubiquitin-like protein Ufm1-is required for the maintenance of normal cardiac structure and function and protects against pressure overload-induced pathological cardiac remodeling. Our results support a role for Ufl1 in regulating ER homeostasis via sustaining PERK signaling in the heart (Figure 9 ). These findings establish the importance of protein ufmylation in the heart and warrant further experiments to clarify the molecular/cellular actions of Ufl1-mediated ufmylation in the heart and to assess the potential of upregulating myocardial Ufl1 levels as a therapeutic option in heart failure.
In the current study, we have identified Ufl1 as a novel regulator of cardiac homeostasis. We present evidence that implicates dysregulated ufmylation in hypertrophic, ischemic, and dilated cardiomyopathy in both animal models and human patients (Figure 1 ). We further show that mice lacking Ufl1 develop age-dependent dilated cardiomyopathy and are more susceptible to pressure overload-induced heart failure ( Figures 3 and 4) . Interestingly, the loss of Ufl1 in cardiomyocytes leads to a reduced heart size during development ( Figure 3A ) but augmented cardiac hypertrophy in response to pressure overload (Figure 4E) , suggesting that Ufl1 has a dichotomous role in regulating physiological and pathological cardiac growth. The E3 Ufm1 ligase Ufl1 has no obvious sequence similar- ity to any known ubiquitin E3 ligases and has been shown to promote the ufmylation of Ufbp1 (an ER-resident protein), 11 ASC1 (a transcriptional coactivator of estrogen receptor-α), 14 and ribosomal proteins. 50 In agreement with its role as the E3 Ufm1 ligase, we observed a reduction of ufmylated proteins in Ufl1-deficient hearts. The lack of a global change in protein ufmylation in Ufl1 CKO hearts could be because of the presence of other unknown Ufm1 E3 ligases, compensatory activation of protein deufmylation, or enduring ufmylation in noncardiomyocytes in the hearts. Although it is unknown whether ufmylation always requires a dedicated E3 ligase, it is conceivable that an E3 ligase could enhance the Ufm1 modification of cellular targets, as seen in the case of SUMO modification. 51 Thus far, there is no evidence suggesting that Ufl1 has an uncharacterized molecular function beyond ufmylation. Therefore, we propose that Ufl1-mediated protein ufmylation strongly contributes to the maintenance of normal cardiac function.
The ER is a multifunctional subcellular organelle that coordinates the synthesis, folding, assembly, trafficking, and degradation of proteins in eukaryotic cells. Disruption of ER function because of various cellular stressors, such as ischemia, hypoxia, heat shock, oxidative stress, and increased protein synthesis results in ER stress, which has been recognized as an important mechanism underlying the pathogenesis of heart failure. 42, 43 However, the regulatory control of ER stress in cardiomyocytes is incompletely understood. Our study identifies ufmylation as a novel regulator of ER homeostasis in cardiomyocytes. Ufl1 deficiency results in excessive ER stress as evidenced by the dysregulation of ER stress genes, significant increases in ER stress-responsive proteins, and abnormal ER ultrastructure in the heart (Figures 5D and 6 ). The excessive ER stress precedes discernable cardiac dysfunction in Ufl1-deficient hearts, and attenuation of ER stress ameliorates TAC-induced heart failure (Figure 8 ), indicating that persistent ER Mice at 2 mo of age were subjected to transverse aortic constriction (TAC) surgery and immediately received tauroursodeoxycholic acid (TUDCA; 250 mg/kg per d; n=5 for control (CTL) and 7 for KO) or vehicle (n=5 for CTL and 8 for KO) through gavage for 2 wk. A-C, Gross morphology (A), heart weight (Hw)-to-body weight (Bw) ratio (B), and lung weight-to-body weight (Lung/Bw) ratio (C) of indicated mice. D, Echocardiography analysis of cardiac function. E, Quantification of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)+ cardiomyocytes; n=3 mice per group. F and G, Western blot analysis of PDI (protein disulfide isomerase) in heart extracts (F) and the quantification (G); n=3 mice per group. *P<0.05, **P<0.01, ***P<0.001. stress plays a causative role in cardiac dysfunction in Ufl1-deficient hearts. These findings are in line with previous reports that link ufmylation with ER homeostasis. Ufl1 depletion in bone marrow cells has been shown to induce ER stress and impair hematopoiesis. 19 Silencing different components of the ufmylation pathway also enhanced ER stress in a β-cell line. 16 We found that Ufl1 depletion impaired PERK signaling and sensitized cardiomyocytes to ER stress-induced cell death ( Figure 7 ). Cardiac-specific inhibition of PERK signaling exacerbates pressure overload-induced heart failure, 52 supporting the concept that Ufl1-conferred cardioprotection may be mediated by sustained PERK signaling in cardiomyocytes. Interestingly, Ufl1 depletion in bone marrow cells seemed to stimulate both the Xbp-1s and PERK branches of UPR, suggesting that Ufl1 may have cell type-specific effects in initiating the UPR. 19 Nevertheless, more details remain to be understood with regard to how ufmylation controls different branches of ER stress signaling in cardiomyocytes.
Despite the established role of ufmylation in regulation of ER function, exactly how ufmylation regulates ER homeostasis remains unclear, largely because of the elusive identities of bona fide Ufm1 targets. Evidence from several reports suggests that Ufbp1-a putative ER-localized Ufm1 substrate 17 -may be an Ufl1 downstream effector in regulating ER stress. Ufbp1 forms a protein complex with Ufl1 and C53 (also known as Cdk5rap3)-a tumor suppressor that regulates NF-κB signaling 53 -at the cytosolic site of ER. 54 Ufl1 catalyzes Ufm1 conjugation to the lysine 267 of Ufbp1 and stabilizes Ufbp1. 54 Ufbp1 depletion leads to ER stress and elevated PERK signaling in both bone marrow cells and hepatocyte cell lines, 20, 37 possibly because of destabilization of IRE1α. 25 Moreover, germline and somatic deletion of Ufbp1 also causes embryonic lethality and defective hematopoiesis, phenocopying mice deficient in Ufl1. 20 Whether and how Ufbp1 mediates cardioprotective effects downstream of Ufl1 awaits further investigation.
It is worth noting that attenuation of ER stress failed to restore the cardiac function of TAC-operated Ufl1-deficient hearts to the level of CTL+TAC hearts (Figure 8) , indicating that other ER-independent mechanisms contribute. Indeed, our transcriptome analysis reveals that ufmylation may potentially regulate calcium cycling, ribosome function, and metabolism, along with other pathways, in cardiomyocytes ( Figure 5C ), all of which are known to be crucial for the maintenance of cardiomyocyte contractility. 55 As fine-tuning of the calcium concentration in ER is critical for proper protein folding and transport, it will be intriguing to investigate whether dysregulation of Ca 2+ cycling in Ufl1-deficient hearts is the proximal cause of ER stress and heart failure in future studies. Additionally, NF-κB signaling, through cooperation with the nuclear factor of activated T cells pathway, has been shown to potentiate TAC-induced pathological cardiac remodeling. 56 It was previously found that silencing Ufl1 or its interacting partner C53 promotes NF-κB activity. 54 Thus, Ufl1 may restrain NF-κB activation to protect against pathological cardiac hypertrophy.
Our findings suggest that myocardial upregulation of Ufl1 is an adaptive response to pathological insults, such as pressure overload. Hence, a better understanding of how Ufl1 expression is regulated in cardiomyocytes may be helpful to develop new approaches for the treatment of heart failure. Previous studies have reported that the Ufm1 system can be transcriptionally induced by ER stress in mouse embryonic fibroblasts. 18 Specifically, Ufm1 seems to be a potential target of XBP-1, and depletion of XBP-1 can blunt ER stress-induced Ufm1 expression. Interestingly, ER stressinduced upregulation of Ufl1 is not dependent on XBP-1s and PERK signaling, 18 raising the possibility of Ufl1 being the downstream target of ATF6. Activation of ATF6 signaling has been shown to protect against myocardial ischemia/reperfusion damage, 57, 58 which is, in part, mediated by the induction of two of its direct targets in the heart: RCAN1 (regulator of calcineurin 1) and Derl3 (derlin 3). 59, 60 Thus, it will be interesting to test whether Ufl1 acts as another ATF6 direct target to mediate its cardioprotective effect.
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Correspondence to Huabo Su, PhD, Vascular Biology Center, Medical College of Georgia, Augusta University, 1459 Laney Walker Blvd, Augusta, GA 30912. Email hsu@augusta.edu Figure 9 . A model illustrating the role of ufmylation in the heart. Protein ufmylation is mediated by the Ufm1 (ubiquitin-fold modifier 1)-specific enzymes UBA5 (ubiquitin-activating enzyme 5), UFC1 (Ufm1-conjugating enzyme 1), and Ufl1 (Ufm1-specific E3 ligase 1) and is dysregulated under pathological conditions. Myocardial Ufl1 is indispensable for the maintenance of normal heart function and protects against pressure overload-induced cardiac remodeling and heart failure, which is, in part, through ensuring endoplasmic reticulum homeostasis by sustaining adaptive PKR-like ER-resident kinase (PERK) signaling.
